Cannara Biotech Inc. (LOVE : TSX)
Common Stock
$1.76
CAD
+0.06 (3.53%)
Last updated: 2026-06-30
LOVE
Cannara Biotech Inc.
WealthAwesomePerformance
1 Day
+3.53%
1 Week
+10.00%
1 Month
+5.39%
YTD
-4.35%
Key Statistics
Market Cap
$169.91M
52W High
$2.05
52W Low
$1.55
P/E Ratio
15.64
50 Day MA
$1.71
200 Day MA
$1.76
Beta
0.40
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/30/2026 | $1.70 | $1.76 | $1.68 | $1.76 | $1.76 | 26,543 |
| 6/29/2026 | $1.72 | $1.75 | $1.67 | $1.70 | $1.70 | 94,877 |
| 6/26/2026 | $1.58 | $1.68 | $1.58 | $1.68 | $1.68 | 81,672 |
| 6/25/2026 | $1.56 | $1.60 | $1.56 | $1.60 | $1.60 | 42,344 |
| 6/24/2026 | $1.59 | $1.59 | $1.55 | $1.55 | $1.55 | 23,369 |
| 6/23/2026 | $1.60 | $1.62 | $1.56 | $1.60 | $1.60 | 41,175 |
| 6/22/2026 | $1.64 | $1.68 | $1.61 | $1.62 | $1.62 | 47,416 |
| 6/19/2026 | $1.60 | $1.65 | $1.60 | $1.65 | $1.65 | 42,846 |
| 6/18/2026 | $1.64 | $1.66 | $1.60 | $1.60 | $1.60 | 35,674 |
| 6/17/2026 | $1.66 | $1.71 | $1.61 | $1.64 | $1.64 | 54,297 |
Analyst Price Targets
Based on analyst covering LOVE
Wall Street analysts forecast LOVE stock price to rise 81.1% over the next 12 months.
Consensus
No RatingAvg. Target
C$3.19
+81.1% Upside
Current Price
C$1.76
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LOVE's historical volatility
30-Day Vol
32.2%
Annualized
90-Day Vol
33.4%
Annualized
Trend (90d)
-16.4%
Annualized drift
90d Mean
C$1.66
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.73 | C$1.54 – C$1.93 |
| 60 trading days | C$1.69 | C$1.45 – C$1.98 |
| 90 trading days | C$1.66 | C$1.37 – C$2.01 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Cannara Biotech Inc.
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
Financials
- Revenue (TTM)
- $113.01M
- EBITDA
- $23.94M
- Profit Margin
- 8.99%
- ROE (TTM)
- 9.48%
- EPS (Diluted)
- 0.11
- Book Value
- 1.22
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About LOVE
Articles Featuring LOVE.TO
Latest articles and analysis covering LOVE.TO
Why Cannara Biotech Inc. stock is rising today
Cannara Biotech Inc. has seen a 3.53% rise in its stock today, driven by strategic acquisitions and a solid market position in Québec's cannabis sector.
Why Cannara Biotech Inc. stock is gaining today
Cannara Biotech Inc. (LOVE.TO) is experiencing a positive shift in its stock price, reflecting investor confidence in its recent financial achievements and strategic initiatives.
Why Cannara Biotech Inc. stock is gaining today
Cannara Biotech Inc. stock has gained 1.22% today, closing at CA$1.66, buoyed by its record financial performance and strategic moves to enhance market access.
Why Cannara Biotech Inc. stock is tanking today
Cannara Biotech Inc. experienced a 1.20% decline in stock price today, closing at CA$1.64. This drop may reflect investor concerns about the company's future growth prospects despite recent acquisitions and financial achievements.
Why Cannara Biotech Inc. stock is sliding today
Cannara Biotech Inc. (LOVE.TO) closed down 2.41% at CA$1.62, reflecting investor concerns about the cannabis sector's volatility and the company's future performance.
